Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212036 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Xin Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: Dronabinol, Placenta, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Δ9-Tetrahydrocannabinol (THC) is the primary psychoactive component of cannabis which is being increasingly consumed by pregnant people. In humans, THC is sequentially metabolized in the liver to its circulating metabolites 11-hydroxy-THC (11-OH-THC, psychoactive) and 11-nor-9-carboxy-THC (THC-COOH, non-psychoactive). Human and macaque data show that fetal exposure to THC is considerably lower than the corresponding maternal exposure. Through perfused human placenta studies, we showed that this is due to the active efflux of THC (fetal-to-maternal) by a placental transporter(s) other than P-glycoprotein or breast cancer resistance protein. The identity of this placental transporter(s) as well as whether THC or its metabolites are substrates or inhibitors of hepatic solute carrier transporters is unknown. Therefore, we investigated whether 5 μM THC, 0.3 μM 11-OH-THC, and 2.5 μM THC-COOH are substrates and/or inhibitors of placental or hepatic solute carrier transporters at their pharmacologically relevant concentrations. Using HEK cells overexpressing human OATP1B1, OATP1B3, OATP2B1, OCT1, OCT3, OAT2, OAT4, or NTCP, and prototypic substrates/inhibitors of these transporters, we found that THC and THC-COOH were substrates but not inhibitors of OCT1. THC-COOH was a weak substrate of OCT3 and a weak inhibitor of OAT4. THC, 11-OH-THC, and THC-COOH were found not to be substrates/inhibitors of the remaining transporters investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, USA.
- SOLVO Biotechnology, Charles River Laboratories Hungary, Irinyi József u. 4-20, 1117 Budapest, Hungary.
ORCID-Profile: Xin Chen, Jashvant D Unadkat
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Chen, X., Gáborik, Z., Mao, Q., & Unadkat, J. D. (2024). Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212036
Vancouver
Chen X, Gáborik Z, Mao Q, Unadkat JD. Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212036
BibTeX
@article{Chen2024,
author = {Chen, Xin and Gáborik, Zsuzsanna and Mao, Qingcheng and Unadkat, Jashvant D},
title = {Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212036}
}
EUVIMED